An inspirational Inverclyde mum will rack up the miles in a gruelling 10k event this weekend – just days after undergoing her 30th round ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the most promising future stocks according to Wall Street analysts.

Emerging treatments for low-grade serous ovarian cancer and platinum-resistant disease offer new hope, with promising data ...

A new formulation of the drug paclitaxel may help overcome some common limitations of chemotherapy drugs, setting the stage ...

An 'Oura' of Lymphoma; When Doctor Says 'Yes,' Insurer 'No'; Prioritizing Survival Her Oura Ring fitness tracker tipped her ...

Swiss biotech start-up Baxiva AG will receive $3 million to develop a multivalent glycoconjugate vaccine that targets ...

Drug affordability varied considerably, with the highest median affordability in Europe and the Western Pacific and the ...

Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than ...

University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer ...

Cook Medical announced that the FDA has granted approval for the company to initiate an investigational device exemption (IDE ...

Novocure (NASDAQ: NVCR) today announced it submitted a premarket approval (PMA) application to the U.S. Food and Drug Administration (FDA) for Tumor Treating Fields (TTFields) therapy for the ...